WELT develops digital biomarkers and digital therapeutics that utilize smartphone and sensor data to monitor and predict health outcomes. The platform delivers personalized therapies to manage and prevent diseases, addressing the need for effective, data-driven healthcare solutions.
Funding
$21.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
EPFounders
Product
Problem
Current methods for monitoring and managing health conditions often rely on infrequent clinical visits and patient self-reporting, leading to delayed interventions and suboptimal outcomes. Traditional healthcare solutions lack the ability to continuously track patient health data in real-world settings and deliver personalized interventions.
Solution
WELT offers a platform that utilizes digital biomarkers and digital therapeutics to continuously monitor and manage health conditions. By leveraging smartphone and sensor data, the platform tracks, monitors, and predicts health outcomes. The platform delivers personalized, guideline-recommended therapies to manage, treat, and prevent diseases and disorders, providing data-driven healthcare solutions.
Target Audience
The primary target audience includes healthcare providers, hospitals, and pharmaceutical companies seeking to improve patient outcomes through continuous monitoring and personalized interventions, as well as patients with chronic conditions who can benefit from remote monitoring and tailored therapies.
Features
- Collection of real-time health data through smartphone sensors and wearable devices
- Analysis of collected data to generate digital biomarkers for various health conditions
- Personalized digital therapeutic interventions based on individual patient data and clinical guidelines
- Remote patient monitoring and alerts for timely intervention
- Integration with existing healthcare systems and electronic health records (EHRs)